Back to Awarded Treatment Trials
Awarded Trial: 13T-015
Grant ID
13T-015
Illness
schizophrenia
Primary Drug/Intervention
canakinumab
Primary Dosage
N/A
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Weickert
Sample Size
30
Duration of Study Period for Each Subject
56 days
Outcome Measurements
N/A
Results
N/A
Publication
N/A
Link
N/A
PI Name
Thomas Weickert
Degree
N/A
Center
Neuroscience Research Australia
Institution
University of New South Wales
Address
Barker Street
City or Town
Randwick
State or Province
New South Wales
Zip or Postal Code
2031
Country
Australia
Email Address
t.weickert@neura.edu.au